Finding new drugs to stop tau protein buildup in Alzheimer's disease
Development and validation of a high throughput screening assay for identification of tau aggregation inhibitors in Alzheimer's disease
This study is looking for new drugs that can stop tau proteins from clumping together in the brain, which is important for finding better treatments for Alzheimer's disease, so that patients can have more options to help slow down the effects of the illness.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Hlth Sci Ctr Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10872912 on NIH RePORTER |
What this research studies
This research focuses on developing a new method to identify drugs that can inhibit the aggregation of tau proteins, which are linked to the progression of Alzheimer's disease. Using a technique called protein misfolding cyclic amplification (PMCA), the researchers aim to create a high-throughput screening assay that can efficiently test potential tau inhibitors. By understanding how tau aggregates form and spread in the brain, the study seeks to discover effective treatments that could slow down or halt the neurodegeneration associated with Alzheimer's. Patients may benefit from new therapeutic options that target the underlying mechanisms of the disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk of developing it.
Not a fit: Patients with other forms of dementia unrelated to tau pathology may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly slow the progression of Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in targeting tau aggregation, but this specific approach using PMCA is relatively novel.
Where this research is happening
Houston, United States
- University of Texas Hlth Sci Ctr Houston — Houston, United States (Active)
Researchers
- Principal investigator: Soto, Claudio — University of Texas Hlth Sci Ctr Houston
- Study coordinator: Soto, Claudio
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.